C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor

  1. Anthony W Azevedo
  2. Thuy Doan
  3. Hormoz Moaven
  4. Iza Sokal
  5. Faiza Baameur
  6. Sergey A Vishnivetskiy
  7. Kristoff T Homan
  8. John J G Tesmer
  9. Vsevolod V Gurevich
  10. Jeannie Chen
  11. Fred Rieke  Is a corresponding author
  1. University of Washington, United States
  2. Keck School of Medicine of University of Southern California, United States
  3. Vanderbilt University School of Medicine, United States
  4. University of Michigan, United States

Abstract

Rod photoreceptors generate measurable responses to single-photon activation of individual molecules of the G-protein-coupled receptor, rhodopsin. Timely rhodopsin desensitization depends on phosphorylation and arrestin binding, which quenches G-protein activation. Rhodopsin phosphorylation has been measured biochemically at C-terminal serine residues, suggesting that these residues are critical for producing fast, low noise responses. The role of native threonine residues is unclear. We compared single-photon responses from rhodopsin lacking native serine or threonine phosphorylation sites. Contrary to expectation, serine-only rhodopsin generated prolonged step-like single-photon responses that terminated abruptly and randomly, whereas threonine-only rhodopsin generated responses that were only modestly slower than normal. We show that the step-like responses of serine-only rhodopsin reflect slow and stochastic arrestin binding. Thus, threonine sites play a privileged role in promoting timely arrestin binding and rhodopsin desensitization. Similar coordination of phosphorylation and arrestin binding may more generally permit tight control of the duration of G-protein-coupled receptor activity.

Article and author information

Author details

  1. Anthony W Azevedo

    Department of Physiology and Biophysics, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Thuy Doan

    Department of Ophthalmology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Hormoz Moaven

    Departments of Cell & Neurobiology and Ophthalmology, Zilkha Neurogenetic Institute, Keck School of Medicine of University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Iza Sokal

    Department of Physiology and Biophysics, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Faiza Baameur

    Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Sergey A Vishnivetskiy

    Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Kristoff T Homan

    Life Sciences Institute, Departments of Pharmacology and Biological Chemistry, University of Michigan, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. John J G Tesmer

    Life Sciences Institute, Departments of Pharmacology and Biological Chemistry, University of Michigan, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Vsevolod V Gurevich

    Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Jeannie Chen

    Departments of Cell & Neurobiology and Ophthalmology, Zilkha Neurogenetic Institute, Keck School of Medicine of University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Fred Rieke

    Department of Physiology and Biophysics, University of Washington, Seattle, United States
    For correspondence
    rieke@u.washington.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Ronald L Calabrese, Emory University, United States

Ethics

Animal experimentation: This work was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All procedures followed protocols approved by the Institutional Animal Care and Use Committee (protocol 3030-01) of the University of Washington.

Version history

  1. Received: December 9, 2014
  2. Accepted: April 23, 2015
  3. Accepted Manuscript published: April 24, 2015 (version 1)
  4. Version of Record published: May 20, 2015 (version 2)

Copyright

© 2015, Azevedo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,881
    views
  • 480
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anthony W Azevedo
  2. Thuy Doan
  3. Hormoz Moaven
  4. Iza Sokal
  5. Faiza Baameur
  6. Sergey A Vishnivetskiy
  7. Kristoff T Homan
  8. John J G Tesmer
  9. Vsevolod V Gurevich
  10. Jeannie Chen
  11. Fred Rieke
(2015)
C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor
eLife 4:e05981.
https://doi.org/10.7554/eLife.05981

Share this article

https://doi.org/10.7554/eLife.05981

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Amy H Andreotti, Volker Dötsch
    Editorial

    The articles in this special issue highlight how modern cellular, biochemical, biophysical and computational techniques are allowing deeper and more detailed studies of allosteric kinase regulation.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.